Loading
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (1 ops.)
Latest filing published 07 Jan 2026 for Cidara Therapeutics, Inc., €1.4M. Read the official filing
Filing timeline
BuySaleFrank Karbe
Insider track record
Disclosed buys
4
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Frank Karbe: trading record in brief
Filings by Frank Karbe span 4 companies, the busiest being Phathom Pharmaceuticals, Inc., Better Therapeutics, Inc. and Cidara Therapeutics, Inc. The record holds 13 filings, for trades running from 7 July 2021 to 7 January 2026.
In open-market terms, that means 4 purchases worth €95k on one side and 1 sale worth €60k on the other. The totals exclude 3 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 7 share grants.
Most recently, on 7 January 2026, the filings show a transaction worth €1.4M in Cidara Therapeutics, Inc. The last purchase on record was published on 16 December 2024, which is 671 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Frank Karbe
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
7,526 shares@ US$221.5050.9% of flowCommon StockSEC:0001276700-26-000002:0
7,290 shares@ US$219.60100.0% of flowCommon StockSEC:0001610618-25-000102:0
10,500 shares0Common StockSEC:0000950170-25-082458:0
57,500 shares0Common StockSEC:0001610618-25-000012:0
12,500 shares@ US$7.926728.7% of flowCommon StockSEC:0000950170-24-136391:0
Canonical exit: 13 Mar 2025 (T+90)
25,000 shares@ US$10.164571.3% of flowCommon StockSEC:0000950170-24-067365:0
10,500 shares0Common StockSEC:0000950170-24-064820:0
62,500 shares0Common StockSEC:0000950170-23-071939:0
137,005 shares@ €0.664824.0% of flowCommon StockSEC:0000950170-23-035680:0
Canonical exit: 25 Oct 2023 (T+90)
9,000 shares0Common StockSEC:0001209191-23-033007:0
242,424 shares@ €0.75948.4% of flowCommon StockSEC:0000899243-23-011189:0
Canonical exit: 9 Jul 2023 (T+90)
50,000 shares@ €2.096327.6% of flowCommon StockSEC:0000899243-22-031206:0
Canonical exit: 14 Dec 2022 (T+90)
3,232 shares@ US$21.75100.0% of flowCommon SharesSEC:0001209191-21-046171:0
13 of 13 declarations
